Covered recipient · General Payments record
ABDUL HUSSEIN MAZIN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$7,602.94
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $887.56 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| LivaNova USA, Inc. | $531.54 | 13 |
| NOBELPHARMA AMERICA, LLC | $202.97 | 2 |
| NEUROPACE, INC. | $86.62 | 1 |
| JAZZ PHARMACEUTICALS INC. | $45.83 | 1 |
| UCB, Inc. | $20.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $45.83 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150216772 | CMS |
| LivaNova USA, Inc. | $6.30 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789609 | CMS |
| LivaNova USA, Inc. | $17.45 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789615 | CMS |
| LivaNova USA, Inc. | $100.87 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789617 | CMS |
| LivaNova USA, Inc. | $9.41 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789611 | CMS |
| LivaNova USA, Inc. | $18.78 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789699 | CMS |
| LivaNova USA, Inc. | $96.97 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789627 | CMS |
| LivaNova USA, Inc. | $12.68 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789665 | CMS |
| LivaNova USA, Inc. | $8.23 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789703 | CMS |
| LivaNova USA, Inc. | $95.97 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789709 | CMS |
| LivaNova USA, Inc. | $5.32 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789745 | CMS |
| LivaNova USA, Inc. | $110.19 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789741 | CMS |
| LivaNova USA, Inc. | $32.87 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789757 | CMS |
| LivaNova USA, Inc. | $16.50 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789759 | CMS |
| NEUROPACE, INC. | $86.62 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153273838 | CMS |
| NOBELPHARMA AMERICA, LLC | $85.17 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154851013 | CMS |
| NOBELPHARMA AMERICA, LLC | $117.80 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154851103 | CMS |
| UCB, Inc. | $20.60 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143331019 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.